Skip to main content

Table 1 Baseline Characteristics of the Study Population

From: Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis

Study MADa PKPDb OCEANd
Subjects/Patients Postmenopausal women Postmenopausal women Postmenopausal women with osteoporosis or osteopenia
Number of subjects/ patients 27 10 278
Race 100% Caucasian 100% Caucasian 100% Caucasian
Age (Mean (SD), year) 60.6 (5.7) 63.2 (4.7) 65.3 (4.8)
Weight (Mean (SD), kg) 69.8 (7.4) 71.1 (9.8) 65.4 (9.8)
Height (Mean (SD), cm) 165.2 (5.0) 160.3 (6.0) 160.1 (5.9)
BMI (Mean (SD), kg/m2) 25.6 (2.4) 27.6 (2.7) 25.5 (3.7)
Serum CTX (Mean (SD), ng/mL) 0.550 (0.209) 0.898 (0.171)c 0.739 (0.249)
Urine CTX (Mean (SD), μmol/mmol creatinine) 215 (91) 361 (165) 296 (128)
  1. aOnly 50 mg BID, 100 mg QD and 300 mg QD groups in 15-day cohort. The original study was reported by Nagase et al. [31]
  2. bValue of all predose [28]
  3. cBaseline data of the first period
  4. dFull analysis set in the OCEAN study [16]